The Adaptation, Usability, and Feasibility of a Mobile Health (mHealth) System to Improve Type 2 Diabetes Self-management in Thailand
Primary Purpose
Type 2 Diabetes Mellitus
Status
Completed
Phase
Not Applicable
Locations
Thailand
Study Type
Interventional
Intervention
Mobile health system
E-mail reports and technical support for mHealth system
Sponsored by

About this trial
This is an interventional health services research trial for Type 2 Diabetes Mellitus focused on measuring Mobile health (mHealth)
Eligibility Criteria
Inclusion Criteria:
For patients:
- poorly controlled type 2 diabetes as indicated by HbA1c ≥ 7.5% recorded within past 6 months
- aged 20 years and older
- currently being treated by oral antihyperglycemic
- communicates and reads in Thai
- has access to and able to use a touch-tone phone (either a land line or a mobile phone)
- free of major physical, cognitive, or psychiatric impairment (per medical records and PI discretion) that would prevent them from participating meaningfully in the intervention.
Inclusion criteria:
For nurses:
- works in a non-communicable disease clinic.
- can access email
- has a mobile telephone.
Exclusion Criteria:
For patients:
- have participated in other mHealth interventions within 3 months
- have baseline HbA1c < 7.5%
- are hospitalized or otherwise at risk for hospitalization
- are prescribed injected insulin
- patients and nurses who participated in the usability trial will be ineligible to participate in the pilot trial.
Exclusion criteria:
For nurses: None
Sites / Locations
- Buengbon Health Promoting Hospital
- Buengkasam 1 Health Promoting Hospital
- Buengkasam 2 Health Promoting Hospital
- Buengshamaor 1 Health Promoting Hospital
- Nongsamwang 1 Health Promoting Hospital
- Salakru Health Promoting Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Patient Arm using mHealth
Community nurses
Arm Description
Patients with uncontrolled type 2 diabetes
Nurses who receive mHealth report about patients in the patients' arm.
Outcomes
Primary Outcome Measures
HbA1c
It refers to glycated haemoglobin, which identifies average plasma glucose concentration.
Diabetes related distress
It will be measured using the emotional and regimen subscales of a Thai translation of the well-validated Diabetes Distress Scale. This is a reliable and validated scale, and correlates with other measures of emotional distress. The responses range from 1-6. The higher scores indicate a greater degree of distress.
Secondary Outcome Measures
Fasting blood glucose
It refers to blood glucose levels after refraining eating or drinking for at least 8 hours.
Full Information
NCT ID
NCT03078764
First Posted
March 7, 2017
Last Updated
December 20, 2017
Sponsor
University of Michigan
Collaborators
Mahidol University, Fogarty International Center of the National Institute of Health
1. Study Identification
Unique Protocol Identification Number
NCT03078764
Brief Title
The Adaptation, Usability, and Feasibility of a Mobile Health (mHealth) System to Improve Type 2 Diabetes Self-management in Thailand
Official Title
The Adaptation, Usability, and Feasibility of a Mobile Health (mHealth) System to Improve Type 2 Diabetes Self-management in Thailand
Study Type
Interventional
2. Study Status
Record Verification Date
December 2017
Overall Recruitment Status
Completed
Study Start Date
June 9, 2017 (Actual)
Primary Completion Date
December 1, 2017 (Actual)
Study Completion Date
December 1, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Michigan
Collaborators
Mahidol University, Fogarty International Center of the National Institute of Health
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This project explores the feasibility of using automated telephone calls to adult patients with type 2 diabetes to improve diabetes self-management in Thailand. This line of work could significantly extend Thai nurses' ability to manage this growing epidemic, and ultimately reduce the suffering and costs caused by diabetes in Thailand.
Detailed Description
There is a serious shortage of community nurses to address Thailand's significant and expanding burden of poorly controlled type 2 diabetes. However, mobile health (mHealth) strategies are likely to significantly improve and extend Thai nurses' ability to monitor and manage these patients. This study aims to:
1) investigate the feasibility and acceptability of a culturally- and clinically-adapted mHealth intervention with adult Thai diabetic patients and their community nurses, and 2) estimate the intervention's effect upon glycated hemoglobin (HbA1c), fasting blood glucose, self-management behaviors, and diabetes-related distress in uncontrolled type 2 diabetes. Thirty-six patients with poorly controlled type 2 diabetes (along with their regular nurses) will be recruited through an established community clinic network. After baseline clinical and behavioral assessment, patients will receive 12 weeks of automated 10-minute weekly Interactive Voice Response (IVR) calls to provide monitoring and self-management support related to glycemic symptoms, medication adherence, and several self-care behaviors. Patients' clinical nurse will receive weekly summaries of each IVR call by text message and email with guidance on Thai-appropriate best practices. Principal investigator will receive email whenever patients report a potentially urgent issue by IVR, i.e., symptoms of hypoglycemia, or inadequate supply of medication. Immediately after the 12-week intervention concludes, clinical and behavioral variables will be reassessed and a mixed-methods process evaluation will be performed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes Mellitus
Keywords
Mobile health (mHealth)
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
42 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Patient Arm using mHealth
Arm Type
Experimental
Arm Description
Patients with uncontrolled type 2 diabetes
Arm Title
Community nurses
Arm Type
Experimental
Arm Description
Nurses who receive mHealth report about patients in the patients' arm.
Intervention Type
Other
Intervention Name(s)
Mobile health system
Other Intervention Name(s)
mHealth, Interactive Voice Response (IVR)
Intervention Description
Patients will receive weekly automated IVR telephone calls for 12 weeks to assess their glycemic symptoms, medication adherence, dietary consumption, physical activity, sleep, and foot care. These 5-10 minute calls will follow a standardized Thai language IVR script developed specifically for this study.
Intervention Type
Other
Intervention Name(s)
E-mail reports and technical support for mHealth system
Intervention Description
Nurses will also receive a technical troubleshooting guide, and have similar access to live telephone technical support. Once their patients' calls begin, nurses will begin receiving weekly e-mail reports summarizing each patients' assessment results, any active self-management problems the patients reported, and suggested strategies for supporting the patient's self-management.
Primary Outcome Measure Information:
Title
HbA1c
Description
It refers to glycated haemoglobin, which identifies average plasma glucose concentration.
Time Frame
13 weeks
Title
Diabetes related distress
Description
It will be measured using the emotional and regimen subscales of a Thai translation of the well-validated Diabetes Distress Scale. This is a reliable and validated scale, and correlates with other measures of emotional distress. The responses range from 1-6. The higher scores indicate a greater degree of distress.
Time Frame
13 weeks
Secondary Outcome Measure Information:
Title
Fasting blood glucose
Description
It refers to blood glucose levels after refraining eating or drinking for at least 8 hours.
Time Frame
13 weeks
Other Pre-specified Outcome Measures:
Title
Sleep quality
Description
It will be assessed using the same single item used during the IVR assessment, along with the PROMIS Sleep Disturbance-Short Form. The PROMIS (Patient-Report Outcomes Information System) Sleep Disturbance-Short Form is a 4-item self-report instrument covering the quality of sleep-wake functioning. Responses are scored on a 5-point Likert scale. The higher scores indicating a greater degree of sleep disturbance.
Time Frame
13 weeks
Title
Dietary consumption
Description
It will be assessed using the same single item used during the IVR assessment. The responses range from 0 to 7 (days).
Time Frame
13 weeks
Title
Physical activity
Description
It will be assessed using the Stanford Leisure-Time Activity Categorical Item (Kiernan et al., 2013), which consists of 6 descriptive categories ranging from inactive (1) to very active, almost daily physical activity (6).
Time Frame
13 weeks
Title
Foot care
Description
It will be assessed using the same single item used during the IVR assessment. The responses range from 0 to 7 (days).
Time Frame
13 weeks
Title
Symptoms of hypoglycemia
Description
It will be assessed using a 7 items that ask about low blood sugar symptoms, the same that the study team describe in the IVR calls. The responses range from 0 (not at all) to 4 (6-7 days a week). The higher scores indicate a greater degree of hypoglycemic symptoms.
Time Frame
13 weeks
Title
Depressive symptoms severity
Description
It will be assessed using the Patient Health Questionnaire-8 (PHQ-8) (Kroenke et al., 2009). It consists of 8 items with a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). Higher scores indicate greater depressive symptom severity.
Time Frame
13 weeks
Title
Readiness for change
Description
It will be assessed using 5 items from our prior research that is specifically worded to measure participants'preparedness to change the 5 diabetes self-care behaviors that our program targets, which are answered using a 7-point Likert scale ranging from 1 (not at all) to 7 (very much so). Higher scores indicate greater readiness for change.
Time Frame
13 weeks
Title
Diabetes self-efficacy
Description
It will be assessed with the Self-Efficacy for Diabetes Scale (Ritter et al., 2016). The scale consists of 8 items with 10- point Likert scale ranging from 1 (not at all confident) to 10 (totally confident). Higher scores indicate greater self-efficacy.
Time Frame
13 weeks
Title
Medical adherence
Description
It will be assessed using the Hill-Bone Compliance Scale (Kim et al., 2000), assesses how often patients miss taking medications, rated on a 4-point Likert scale ranging from 1(none of the time) to 4 (all of the time). In the study, only 8 items of Hill-Bone Compliance scale will be used. Reverse coded before analysis will be performed. Higher scores indicate greater medication adherence. In addition, 1-item of the Brief Medication Questionnaire will be used, which allows calculation of percent adherence over the past 2 weeks
Time Frame
13 weeks
Title
Social support
Description
It will be assessed using selected items from the Norbeck Social Support Questionnaire, which is a validated measure of number, type, and quality of relationships (Norbeck, 1983). For the purpose of this study, the 6 items (item 3-8) will be scored on a 5-point Likert scale ranging from 0 (not at all) to 4 (a great deal). Higher scores indicate better social support.
Time Frame
13 weeks
Title
Health literacy
Description
It will be assessed using the 3-item screener developed by Chew et al. for detecting probable inadequate health literacy (45, 46). Higher scores indicate better health literacy.
Time Frame
13 weeks
Title
Client satisfaction
Description
will be measured using the Client Satisfaction Questionnaire (CSQ-8) (Attkisson, Zwick, 1982), which assesses satisfaction with specific providers, settings, and time intervals, along with open-ended items (within the exit interview) adapted from prior mHealth research studies. Higher scores indicate greater satisfaction of the program.
Time Frame
13 weeks
Title
Self-efficacy (for nurse)
Description
It will be measured using Nurse Self-efficacy for Diabetes Care using 11 items developed for this study that correspond to patients' IVR content areas.
Time Frame
13 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
For patients:
poorly controlled type 2 diabetes as indicated by HbA1c ≥ 7.5% recorded within past 6 months
aged 20 years and older
currently being treated by oral antihyperglycemic
communicates and reads in Thai
has access to and able to use a touch-tone phone (either a land line or a mobile phone)
free of major physical, cognitive, or psychiatric impairment (per medical records and PI discretion) that would prevent them from participating meaningfully in the intervention.
Inclusion criteria:
For nurses:
works in a non-communicable disease clinic.
can access email
has a mobile telephone.
Exclusion Criteria:
For patients:
have participated in other mHealth interventions within 3 months
have baseline HbA1c < 7.5%
are hospitalized or otherwise at risk for hospitalization
are prescribed injected insulin
patients and nurses who participated in the usability trial will be ineligible to participate in the pilot trial.
Exclusion criteria:
For nurses: None
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Panan Pichayapinyo, PhD.
Organizational Affiliation
University of Michigan
Official's Role
Principal Investigator
Facility Information:
Facility Name
Buengbon Health Promoting Hospital
City
Nong Sua
State/Province
Pathumthani
ZIP/Postal Code
12170
Country
Thailand
Facility Name
Buengkasam 1 Health Promoting Hospital
City
Nong Sua
State/Province
Pathumthani
ZIP/Postal Code
12170
Country
Thailand
Facility Name
Buengkasam 2 Health Promoting Hospital
City
Nong Sua
State/Province
Pathumthani
ZIP/Postal Code
12170
Country
Thailand
Facility Name
Buengshamaor 1 Health Promoting Hospital
City
Nong Sua
State/Province
Pathumthani
ZIP/Postal Code
12170
Country
Thailand
Facility Name
Nongsamwang 1 Health Promoting Hospital
City
Nong Sua
State/Province
Pathumthani
ZIP/Postal Code
12170
Country
Thailand
Facility Name
Salakru Health Promoting Hospital
City
Nong Sua
State/Province
Pathumthani
ZIP/Postal Code
12170
Country
Thailand
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
The Adaptation, Usability, and Feasibility of a Mobile Health (mHealth) System to Improve Type 2 Diabetes Self-management in Thailand
We'll reach out to this number within 24 hrs